Idelalisib Enrolling by Invitation Phase N/A Trials for B-Cell Malignancies

IndicationsStatusPurposePhase
Enrolling by InvitationNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03701438Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib